Showing results (81-90 of 145) with videos related to
Sort By:
Pageof 15
Minerva Dietologica E Gastroenterologica|October 1, 1990
[Prevention of duodenal ulcer recurrence by the use of anti H2. Comparison of continuous long-term and seasonal therapy]S Tarantino, G Sisto, D Lorusso, et al.Oncology|August 11, 2011
Phase II study on weekly bolus topotecan in advanced or recurrent cervical cancerD Lorusso, S Mainenti, A Pietragalla, et al.American Journal of Medical Genetics|December 1, 1990
Baller-Gerold syndrome: an 11th case of craniosynostosis and radial aplasiaJ M Boudreaux, M A Colon, G D Lorusso, et al.Clinical and Experimental Obstetrics & Gynecology|January 1, 1995
Maternal ultrasound bone density in normal pregnancyP Paparella, R Giorgino, A Maglione, et al.Oncology|August 15, 2013
The different impact of BRCA mutations on the survival of epithelial ovarian cancer patients: a retrospective single-center experienceD Lorusso, F Cirillo, M Mancini, et al.Journal of X-Ray Science and Technology|July 30, 2019
Extending the dynamic range of biomedical micro-computed tomography for application to geomaterialsD R Edey, S I Pollmann, D Lorusso, et al.Oncology|January 11, 2001
Topotecan and gemcitabine in platinum/paclitaxel-resistant ovarian cancerS Greggi, M G Salerno, G D'Agostino, et al.American Journal of Surgery|June 1, 1990
Duodenogastric reflux of bile acids, gastrin and parietal cells, and gastric acid secretion before and 6 months after cholecystectomyD Lorusso, G Misciagna, V Mangini, et al.Gynecologic Oncology|February 1, 2011
Is surgical restaging indicated in apparent stage IA pure ovarian dysgerminoma? The MITO group retrospective experienceG Mangili, C Sigismondi, D Lorusso, et al.British Journal of Cancer|October 2, 2003
Phase II study of liposomal doxorubicin and gemcitabine in the salvage treatment of ovarian cancerG D'Agostino, G Ferrandina, M Ludovisi, et al.Pageof 15